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P1 THE NINFEA PROJECT: ONE YEAR OF WORK
L. Giannotta, D. Falciatore1, F. Piccolantonio, L. Ratclif2. 1Family doctor, Italy;
2U.O.S. Cystic Fibrosis Cerignola, Italy
The NINFEA project has been established as a system of communication between
Cerignola and the family doctors in the area. The aim of the project consists on
providing to the patient a two-way assistance (hospital and family doctors). In this
way there is a sort of continuity in the patient’s care, which makes treatment of the
illness more adequate for him and his family.
The project has started after a specialization course on cystic ﬁbrosis consisting of
six meetings held monthly.
According to the project, the family doctor should do: monthly ﬁrst-aid visits
planned for the evaluation of the patient, and house visits in case the illness gets
worse. At the end of the visit the doctor sends via internet to the support Service
and to all the other doctors involved in the project (newsgroup), a form containing
the necessary anonymous data.
The project involves eighteen doctors caring for thirty-two patients affected with
cystic ﬁbrosis, three of whom were diagnosed during the ten months of NINFEA
activity.
In order to evaluate the effectiveness of the project, we have made a sort of quality
comparison between quality indicators, decided by comparing the ten activity
months (December 2006-September 2007) with the ten months of hospital activity
preceding the beginning of NINFEA (February-November2006).
The results are the following:
– The number of visits made by the hospital service has decreased from 258 to 78;
– Visits made from the doctors of NINFEA area: 266;
– The total n. of hospitalization days has decreased from 79 to 26;
– The total n. of days providing an antibiotical therapy has increased from 156 to
257;
– The complications set in have decreased from 2 to 0.
Moreover we have submitted the same questionnaire before the beginning of and a
year after the project to the 16 involved families, to which other 3 have added, for
a total of 19 families. Here is a list of the results:
• Satisfaction for the job made by the doctor in controlling the illness (before and
after NINFEA project):
– “not satisﬁed” from 68% to 3%;
– “poorly satisﬁed” from 27% to 5%;
– “enough satisﬁed” from 5% to 70%
– “very satisﬁed” from 0% to 22%.
• Do you feel now safer about the management and the control of the illness?
yes = 79%; no = 21%;
• Do you think there was an improvement in the way of treating the illness? yes =
85.5%; no = 14.5%.
These results show a clear improvement of patient management and support the
cooperation between the hospital and the area in treatment of Cystic Fibrosis.
P2 PROLONGING THE DURATION OF PERIPHERAL VENOUS
CATHETERS IN CYSTIC FIBROSIS PATIENTS. RANDOMIZED
CONTROLLED STUDY ON THE EFFECT OF DIFFERENT
CONCENTRATIONS OF ANTIBIOTICS IN NORMAL SALINE
F. Festini, S. Neri, G. Taccetti, T. Repetto, C. Braggion. Centro FC della Toscana,
Ospedale Meyer, Universita` di Firenze, Florence, Italy
Background: Patients with CF frequently have to undergo IV antibiotic courses.
Peripherally inserted indwelling devices (PVC) are used to reduce the number of
venipunctures. The irritating action of antibiotics may interrupt the vein’s patency,
requiring numerous venipunctures to a patient to complete a course of antibiotic
treatment, which usually lasts 2 weeks, causing further suffering, pain and anxiety.
With the passing of time veins become difﬁcult to ﬁnd and the completion of a
course may become a problem and cause suffering to the patient.
An alternative to PVC are Central Venous Catheters but such an invasive interven-
tion may not be indicated due to patients’ clinical conditions.
A preliminary cohort study was carried out (Festini, Assist Inferm Ric
2005;24:91−6) which showed a correlation between the number of daily antibiotic
infusions and the duration on site of PVCs, suggesting that a higher dilution of
antibiotic may reduce its irritating action on the vein.
Goal: To investigate whether, administering the prescribed IV antibiotic with an
increased dilution in Normal Saline, it is possible to reduce the irritation on the
vein, reduce the risk of phlebitis and prolong the duration of the PVC, therefore
reducing the number of venipunctures needed to complete an antibiotic course.
Subjects and methods: Non blinded RCT, carried out at the CF Center of Tuscany,
Italy. CF adult subjects are recruited, to whom a 2-week IV antibiotic course with
ceftazidime and tobramycin is prescribed due to exacerbation.
Results: The recruitment started in March 2007. So far 6 patients were eligible
for the study and 4 were included. 2 were randomly assigned to group A – normal
antibiotic dilution – and 2 to group B – higher antibiotic dilution. Preliminary
results and interim analysis show that in Group A, the mean duration of PVCs was
3.75 days (SD 0.75), whereas in Group B, the mean duration of PVCs was 6.45
days (SD 0.07), T-test: p = 0.009. No statistically signiﬁcant differences resulted
with regard to phlebitis, inﬁltration and pain scores.
Discussion: Preliminary data seem to conﬁrm that an increased dilution of antibiotic
in NS may lead to increase the duration on site of PVCs. However, no conclusion
can be drawn so far. The study will continue until the end of 2008. If the hypothesis
is conﬁrmed, an easy, safe and economic method will be available to reduce the
number of venipunctures needed to complete an IV antibiotic course.
CDC/FDA/NIH Clinical Trial Registry n. NCT00418470. FFC Grant 19/2006
P3 HOME INTRAVENOUS ANTIBIOTIC THERAPY IN CYSTIC FIBROSIS
PATIENTS
C. Zappa, A. Raimondi. Centro di Riferimento per la Fibrosi Cistica Regione
Lombardia, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e
Regina Elena, Milan, Italy
Patients with Cystic Fibrosis (CF) suffer from progressive pulmonary disease with
recurrent exacerbations requing intravenous antibiotic therapy. Since 1996 the CF
Center of Lombardia Region accomplished a welfare service to provide patients an-
tibiotic treatments directly at home. This is achieved by means of an agreement with
ONLUS institutions. This experience increased in recent years, thanks to a growing
spread of welfare home services (ADI) to frail people (DGR 12902/09.05.2003
“Voucher Socio-Sanitario sul Territorio Lombardo”). This is a service consisting of
high to middle attendance in order to keep patients in their everyday environment as
long as possible as well as to avoid improper hospitalisation. However, home intra-
venous therapy is always dependent on medical, individual and family conditions.
Over one year period, a total of 167 home treatments were accomplished: 102
patients (44 males, mean age 23.5 years, range 14 months–4 years, 73% adults).
Home intravenous antibiotic therapy was applied to 65 patients who needed a single
cycle of intravenous therapy per year and 37 patients who needed multiple cycles
per year. Home intravenous antibiotic therapy was managed directly by patients or
their relatives in 64% of cases, by local services with the family’s support in 31.2%
of cases, while only 4.8% of cases were managed exclusively by domiciliary local
services. Treatments made at home covered 73% of the whole treatment time; only
5% of patients kept their complete daily activities and relationships such as school
or job. Furthermore, 10 patients, 8 of whom were adults, had the entire treatment
without a single day of hospitalization. Home intravenous antibiotic therapy was
effective in 96% of cases, with a signiﬁcant improvement, in FEV1 from baseline
to end of treatment values. Complications were scarce and of minor importance.
We conclude that home intravenous antibiotic therapy was very useful, well tolerated
as well as economically opportune.
P4 THE CAIRO PROJECT (COMPARATIVE ANALYSIS OF
INTERNATIONAL CF REGISTRIES OVERVIEWED): ANALYSIS AND
REVIEW OF THE SCIENTIFIC LITERATURE FROM CF REGISTRIES
D. Salvatore, E. Baldo, M.P. Forneris, M.L. Furnari, V. Lucidi, D. Manunza,
I. Marinelli, B. Messore, A.S. Neri, V. Raia, R. Buzzetti, G. Mastella. Italian
CF Research Foundation, Verona, Italy
Scientiﬁc literature based on CF registries worldwide was reviewed with the aim
of evaluating what main topics were carried out and which clinical questions
were answered. The search strategy started from (1) Medline and Embase using
“Cystic ﬁbrosis”[MESH] AND (“Registry”[MESH]) OR registr$) as search terms;
(2) Direct information from the CF registries; it was updated to the 30/06/07.
Inclusion criteria were: primary studies which starting from a Registry utilized
data drawn from that Registry to verify research hypothesis. 107 articles were
selected by 2 independent assessors on the basis of their pertinence. Articles were
examined with a form evaluating skills of different Registry data, selected clinical
characteristics of the study populations and statistical methods. Studies were from
USA-CFF (45%), Canada (2%), UK (13%), France (13%), Italy (3%), Germany
(3%), and other European Registries. A set of articles came from the ESCF-USA
study (11%). The main focuses of the articles were: (1) Incidence/prevalence and
survival (27 studies); (2) neonatal screening, growth and nutrition (23); (3) Clinical
genetics (15); (4) complications and outcomes (ABPA, CFRD, pregnancy etc) (35);
(5) microbiology (7).
Main results are: (1) Increasing survival accounts for speciﬁc prognostic factors
(2) Incidence rates are very variable in different countries (3) Genotype/phenotype
studies conﬁrm the severity of F508del mutation and the role of class mutation
(4) Newborn screening conﬁrms beneﬁts on growth and morbidity, but effect on
lung disease and survival is still far to demonstrate (5) There is no consensus on
correct deﬁnition of malnutrition (6) The pregnancy is an increasing event with
positive outcomes (7) Increasing prevalence of complications with age and their
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correlation with survival (8) It is necessary to deﬁne criteria for the best selection
and timing for candidates to lung transplantation.
Registries are an important source of data to investigate clinical and research
questions. This review points out that only in some instances (incidence/survival
analysis) CF Registries are fully able to answer to questions relevant for research.
The main limits concern the analysis of historical cohorts in spite of the large
number of patients registered. It should be demanded to standardize deﬁnitions
of variables, outcome measures and timing of data collection to make results
comparable among Registries.
P5 USE OF NIV IN THE DRAINING THERAPY: CLINICAL CASE
M.A. Ciciretti, L. Ratclif. UOS Cystic Fibrosis Cerignola, Italy
Studies show that the use of NIV, in Cystic Fibrosis, has a positive effect on the
chronic respiratory insufﬁciency in patients affected by advanced pulmonary disease
and/or in waiting lists for a pulmonary transplant, by improving gas transfers and
reducing muscular work.
For this reason we decided to use NIV as support to the draining therapy, focusing
on the following aims:
• improving the compliance of the patient;
• improving the efﬁcacy of the physiotherapeutic treatment;
• estimating the course of the illness.
Clinical case: a male patient, 10 years old, affected by Cystic ﬁbrosis with pancreatic
insufﬁciency and chronically colonized by Pseudomonas aeruginosa. The data in
the table referto the 12 months before NIV and to the NIV* months.
before NIV NIV* months
Physiotherapeutic activity 2−3 sessions per day with PEP-Mask 1 session of NIV and 1 session of
PEP-Mask
Height 130 cm (P) → 132 cm (P) + 132 cm (P) → 137.5 cm (P) +
Weight 28 (P) → 29 Kg (P) + 29.2 Kg (P) → 32 Kg (P) +
Spirometry FEV1 57.7% FEV1 68.4%
Sputum 40 cc with stamps 40cc + ﬂuid without stamps
6 WT 500 mt. with breaks for cough 540 mt. without cough
RX 19 9
Period in bed 52 days No day
Therapy period 56 days (ev) 94 days (os) 16 days (ev) 25 days (os)
Compliance VAS 2 VAS 6
Symptomatology wheezing cough, tiring expectoration, chest
tightness
easy expectoration, no chest tightness.
Also improved PEP session
Tolerance of effort Reduced during physical activity good (gym)
*Resmed pressometric ventilator VPAP III ST-A with nasal mask.
Draining session with 4−5 cycles if C-PAP per 3 days with 7 cm H2O→ use of
Coach 2 (respiratory incentive), 3 fast inspirations and 3 slow ones. → Hufﬁng
Conclusions: the use of the ventilator during a draining therapy produced the
following results:
– Improving the compliance: this was possible because the draining therapy has
been less tiring, faster, with no chest tightness, with a better approach of the
patient to practise the draining session and to require it in case of obstruction.
– Obtaining a better efﬁcacy of the physiotherapeutic treatment: a more ﬂowing
sputum, a relevant reduction of the air instability, a better tolerance of effort.
– Recording positive effects on the course of the illness: spirometric increase,
therapy period reduction, no admission, better saturated-ponderal increase, ra-
diological improvement.
P6 COMPARISON OF HIGH FREQUENCY CHEST WALL OSCILLATION
(HFCWO) AND PEP-MASK IN HOSPITALIZED PATIENTS WITH
CYSTIC FIBROSIS (CF)
F. Alatri, B. Giacomodonato, T. Perelli, L. Graziano, M. Varchetta, G. Cimino,
L. Locorriere, E. Bonci, S. Quattrucci. Centro Fibrosi Cistica Regione Lazio,
Rome, Italy
Background: Reducing bronchial obstruction plays a primary role in the rehabili-
tation of patients with CF. In the last decades treatment has shifted gradually from
passive and tiring techniques to methods that foster self-management of pulmonary
disease, including the use of mechanical tools to loosen secretions. However, the
greater efﬁcacy of such mechanical methods compared to other procedures has not
been demonstrated clearly.
Aim: To compare the efﬁcacy of HFCWO with that of PEP-Mask in the clearance
of bronchial tubes from secretion.
Methods: 10 patients with CF (4 males, average age 21.4±7.5 years) hospitalized
for a relapse of broncho-pulmonary disease. During hospitalization (average length,
6.1±2.7 days) each patient had daily applications of bronchial disobstruction, one
with PEP-Mask and one with HFCWO, each lasting 30 minutes, following standard
procedures. The sequence of the two interventions as changed daily. All patients
were treated with intravenous antibiotics and aerosol bronchodilators. Oxygen was
provided to maintain adequate saturations (SpO2>90%). The following parameters
were evaluated: quantity of ejected humid mucus, SpO2, and heart rate (HR) during
each application of draining physiotherapy, dyspnea and mood assessment using
a visual analogue scale (VAS) at beginning and end of each treatment, FEVI
and WT6min at the start and end of hospitalization, and end-study evaluation
questionnaire. Statistical signiﬁcance was evaluated with the Paired T-Test and
Wilcoxon Signed Rank Test.
Results: Minimum SpO2 during PEP-Mask was 89.3±3.1 vs. 87.2±3.5 during
HFCWO (p< 0.01); average quantity of sputum per treatment was 16±9.6 with
PEP-Mask vs. 10.3±6.5 ml with HFCWO (p< 0.02); HR peak during PEP-
Mask was 116.5±8.8 b/m vs. 120±6.7 b/m for HFCWO (p = 0.08); evaluation
questionnaire showed a perceived greater draining efﬁcacy with PEP-Mask vs.
HFCWO (p< 0.02).
No signiﬁcant differences were identiﬁed for the other parameters.
Conclusions: Compared to HFCWO, treatment with PEP-Mask is associated with
greater draining efﬁcacy, less desaturation, and milder tachycardia in patients with
CF. Studies with larger sample size and longer follow up are warranted.
P7 EFFICACY OF HIGH FREQUENCY CHEST COMPRESSION
(HFCC) IN THE CLEARANCE OF MUCUS IN PATIENTS WITH
CYSTIC FIBROSIS (CF)
M. Ambroni, V. Mazzotti, E. Balestri, S. Dall’Ara, F. Gobbi, F. Lupi, F. Battistini.
Centro Regionale Fibrosi Cistic, Cesena, Italy
Aims: To determinate the efﬁcacy of HFCC (using the VEST) in the clearance
of mucus, by comparing it to the amount of expectorated mucus obtained with
PEP-mask. HFCC is made through a system with an inﬂatable vest, that rapidly
inﬂates and deﬂates to compress and release the chest wall, creating an airﬂow
inside the lungs. This process moves mucus towards the larger airways, where it
can be coughed up and expectorated. PEP-mask is a positive expiratory pressure
generated through a face-mask.
Methods: 10 CF patients (M:W=8:2; mean age=24.3 yrs, range=9−43 yrs),
clinically stable and undergoing their usual therapies (mean FEV1=54.79%,
range=26−93), were randomly recruited. They came twice a week in a 2 weeks
period to perform both VEST and PEP-mask therapy each week (1st day VEST,
2nd day PEP, 3rd day PEP, 4th day VEST).
%SaO2 and cardiac frequency were checked with pulseoximeter every 2min during
each session. We evaluated the emotional state and the fatiguing using VAS scales,
before and after each treatment. The dry expectoration was weighted in laboratory.
HFCC consisted on a VEST treatment of 30min with 3 phases: the ﬁrst consisted
of 7min in a low frequency (8Hz) and pressure (P = 4), the second consisted of
7min at 10Hz and P = 5, and the third of 7min at 15Hz and P = 6. Every phase
was followed by a pause of 3min where they did 3 cough bouts and expectorated.
They did a total of 9 cough bouts followed by expectorations.
PEP-mask consisted of a 30min treatment. Patients did 7min of PEP (with a pause
of 20 sec every 2min) followed by a pause of 3min where they did 3 cough
bouts and expectorated for 3 times. They did a total of 9 cough bouts followed
by expectorations.
Results: See the table.
VEST PEP-mask P value
Sputum gr 34.09±10.28 34.91±9.84 0.483
% SaO2 mean 95.18±1.79 95.49±1.38 0.293
Peak %SaO2 desat 91.90±3.29 91.30±3.05 0.441
% pz VAS amusing 30 10
% pz VAS fatiguing 45 45
Conclusions: VEST is as much effective as PEP-mask technique in clearing sputum
from airways of CF patients. No differences neither in the amount of sputum
expectorated nor in peak SaO2% desaturation were showed. VEST was perceived
as less distressing than PEP-mask, in the same fatiguing condition. So the VEST
may be used as substitute or integrative to PEP, to create an alternative to the classic
chest physical therapy.
Reference(s)
JC Darbee, JF Kanga, Physiologic evidence for HFCWO and positive expiratory
pressure breathing in hospitalized subjects with cystic ﬁbrosis. Physical Therapy,
Vol. 85(12), 2005, 1278–1289
P8 AUTOMATION OF CFTR RE-SEQUENCING: TIME AND COSTS
ANALYSIS
G. Ferraguti1, S. Pierandrei1, S.M. Bruno1, F. Ceci1, A. Di Gioia1, S. Quattrucci2,
R. Strom1, M. Lucarelli1. 1Dept. of Cellular Biotechnologies and Hematology,
2Dept. of Pediatrics, Regional CF Centre, “La Sapienza” University of Rome,
Italy
Among methods for mutational scan of Cystic Fibrosis Transmembrane Conduc-
tance Regulator (CFTR) gene, direct sequencing ensures the highest degree of de-
